Cargando…

Anthropometric parameters as indicators of metabolic derangements in schizophrenia patients stabilized on olanzapine in an Indian rural population

CONTEXT: For any given body mass, Asian Indians have higher central obesity than Europeans. A periodic measurement of body mass index (BMI) and waist hip ratio (WHR) is practically more feasible than other parameters of metabolic syndrome by repeated blood collection. However, few studies are availa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rout, Jayanta Kumar, Dasgupta, Anindya, Singh, Om Prakash, Banerjee, Ushasi, Das, Brahmarshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505316/ https://www.ncbi.nlm.nih.gov/pubmed/23188977 http://dx.doi.org/10.4103/0976-3147.102605

Ejemplares similares

Association of single-nucleotide polymorphism of cholecystokinin receptor A gene with schizophrenia in an Eastern Indian population
por: Rout, Jayanta K., et al.
Publicado: (2015)

A comparative study of oxidative stress and interrelationship of important antioxidants in haloperidol and olanzapine treated patients suffering from schizophrenia
por: Singh, Om Prakash, et al.
Publicado: (2008)

A cross-sectional study to assess any possible linkage of C/T polymorphism in CYP17A1 gene with insulin resistance in non-obese women with polycystic ovarian syndrome
por: Banerjee, Ushasi, et al.
Publicado: (2016)

Role of membrane cholesterol and lipid peroxidation in regulating the Na(+)/K(+)-ATPase activity in schizophrenia
por: Roy, Suparna, et al.
Publicado: (2016)

Metabolic derangements with olanzapine and risperidone in schizophrenia spectrum and other psychotic disorders: A 24-week prospective study
por: Rikhari, Praveen, et al.
Publicado: (2022)

Relationship Between Plasma Olanzapine and N-Desmethyl-Olanzapine Concentration and Metabolic Parameters in Patients With Schizophrenia
por: An, Huimei, et al.
Publicado: (2022)

A Randomized Controlled Trial to Compare the Efficacy, Safety and Tolerability of Asenapine versus Olanzapine in Management of Schizophrenia
por: Maitra, Arpita, et al.
Publicado: (2020)

Anthropometric indicators as predictor of pre-diabetes in Indian adolescents
por: Pandey, Umeshwar, et al.
Publicado: (2017)

Paroxetine combined with olanzapine in the treatment of schizophrenia
por: Wang, Ning, et al.
Publicado: (2020)

Effect of nutritional counselling for using anthropometric indices among Indians
por: Chavan, Sanjay, et al.
Publicado: (2022)

Black hairy tongue with olanzapine: A rare case report
por: Kanodia, Shubhra, et al.
Publicado: (2017)

Application of Plasma Levels of Olanzapine and N-Desmethyl-Olanzapine to Monitor Clinical Efficacy in Patients with Schizophrenia
por: Lu, Mong-Liang, et al.
Publicado: (2016)

Teratogenicity with Olanzapine
por: Prakash, Sathya, et al.
Publicado: (2014)

Effect of Olanzapine on Clinical and Polysomnography Profiles in Patients with Schizophrenia
por: Katshu, Mohammad Zia Ul Haq, et al.
Publicado: (2018)

Derangements in bone mineral parameters and bone mineral density in south Indian subjects on antiepileptic medications
por: Koshy, George, et al.
Publicado: (2014)

Screening of cardiovascular risk assessment accuracy of anthropometric indices in Indian children and adolescents
por: Aggarwal, Mohit, et al.
Publicado: (2021)

Treatise on Mental Derangement, and on Hospitals for the Deranged
Publicado: (1829)

Treatise on Mental Derangement, and on Hospital for the Deranged
Publicado: (1829)

Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis
por: Kerbert, Annarein J. C., et al.
Publicado: (2015)

Effectiveness and safety of oral olanzapine treatment transitioned from rapid-acting intramuscular olanzapine for agitation associated with schizophrenia
por: Katagiri, Hideaki, et al.
Publicado: (2018)

Worth the Weight? Olanzapine Prescribing in Schizophrenia. A Review of Weight Gain and Other Cardiometabolic Side Effects of Olanzapine
por: Fitzgerald, Ita, et al.
Publicado: (2021)

Deranged Pulmonary Function Tests in Allergic Rhinitis in North Indian Patients
por: Monga, Seema, et al.
Publicado: (2019)

Anthropometric Parameters as Indicators of Obesity in Adolescents in Montenegro
por: VASILJEVIC, Ivan
Publicado: (2018)

Anthropometric Indicators as Predictors of Mortality in Early Life Among Low Birthweight Indian Infants
por: Choudhary, Tarun Shankar, et al.
Publicado: (2022)

Change in level of productivity in the treatment of schizophrenia with olanzapine or other antipsychotics
por: Liu-Seifert, Hong, et al.
Publicado: (2011)

A Comparative Study between Olanzapine and Risperidone in the Management of Schizophrenia
por: Shoja Shafti, Saeed, et al.
Publicado: (2014)

Effects of olanzapine on resting heart rate in Japanese patients with schizophrenia
por: Tajiri, Misuzu, et al.
Publicado: (2018)

Subcutaneous Olanzapine at the End of Life in a Patient with Schizophrenia and Dysphagia
por: Hindmarsh, Jonathan, et al.
Publicado: (2020)

Prevalence of diabetes in patients of Schizophrenia on long-term use of olanzapine
Publicado: (2022)

Effects of olanzapine on anhedonia in schizophrenia: mediated by complement factor H
por: Zhang, Yi, et al.
Publicado: (2023)

Lipid derangement as diagnostic and prognostic indicator for visceral leishmaniasis patients
por: Mohapatra, Sarita, et al.
Publicado: (2014)

Effects of long-term therapy with quetiapine and olanzapine on parameters of immunity and cytokine levels in patients with schizophrenia
por: Lobacheva, O., et al.
Publicado: (2021)

The Evolution of Anthropometric and Physiometric Parameters, and of Anthropometric Indices Based on Age and Gender in a Group Of Pupils
por: HUREZEANU, A., et al.
Publicado: (2016)

Genetic Association of Olanzapine Treatment Response in Han Chinese Schizophrenia Patients
por: Zhou, Wei, et al.
Publicado: (2019)

Influence of olanzapine on serum prolactin levels and BMI in female patients with schizophrenia
por: Yang, Fuyin, et al.
Publicado: (2018)

Dysmorphic Delusion and Olanzapine-Induced Postpartum Dermatosis in a Case of Schizophrenia
por: Sutar, Roshan, et al.
Publicado: (2019)

A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future
por: Citrome, Leslie, et al.
Publicado: (2019)

Effect of Co-Treatment of Olanzapine with SEP-363856 in Mice Models of Schizophrenia
por: Liang, Lingzhi, et al.
Publicado: (2022)

Sexual dysfunction in male schizophrenia remitted patients treated with risperidone and olanzapine
Publicado: (2022)

Effect of Haloperidol and Olanzapine on Hippocampal Cells’ Proliferation in Animal Model of Schizophrenia
por: Osacka, Jana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hslv7ak617hbiscvuj6q0vb70c